Germline BRCA pathogenic variants in patients with ovarian cancer and post-poly (ADP-ribose) polymerase inhibitor myeloid neoplasms
Valenza, C., Mongillo, M., Gigli, F., Trapani, D., Katrini, J., Nicolò, E., Boldrini, L., Boscolo Bielo, L., Castellano, G., Guidi, L., Pellizzari, G., Derio, S., Lapresa, M., Parma, G., Derenzini, E., Curigliano, G., Colombo, N.
Published in ESMO open (01.09.2024)
Published in ESMO open (01.09.2024)
Get full text
Journal Article
Interstitial lung disease in patients enrolled in early-phase clinical trials: the ILDE study
Trapani, D., Scalia, R., Giordano, E., Castellano, G., Doi, G., Gaeta, A., Pellizzari, G., Carnevale Schianca, A., Katrini, J., D’Ambrosio, S., Santoro, C., Guidi, L., Valenza, C., Belli, C., Gandini, S., Russo, A., Curigliano, G.
Published in ESMO open (01.08.2024)
Published in ESMO open (01.08.2024)
Get full text
Journal Article
2041P The prevalence of hematologic adverse events (HAEs) and myelodysplastic syndrome/acute myeloid leukemia (MDS/AML) in patients (pts) with advanced high grade ovarian carcinoma (aHGOC) receiving PARP inhibitor (PARPi), with or without a germline BRCA pathogenic variant
Valenza, C., Nicolo, E., Mongillo, M., Trapani, D., Gigli, F., Boldrini, L., Bielo, L. Boscolo, Castellano, G., Guidi, L., Katrini, J., Pellizzari, G., Villa, J., Lorenzetti, I.T., Derio, S., La Presa, M.T., Parma, G., Curigliano, G., Colombo, N.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
710P A retrospective study on the safety and adequacy of fresh biopsies for next generation sequencing in early-phase clinical trials
Crimini, E., Esposito, A., Belli, C., Scafetta, R., Scalia, R., Castellano, G., Giordano, E., Katrini, J., Ascione, L., Repetto, M., Boscolo Bielo, L., Marra, A., Trapani, D., Profeta, T., Varano, G., Maiettini, D., Della Vigna, P., Orsi, F., Criscitiello, C., Curigliano, G.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
2148P Venous thromboembolism (VTE) in patients with advanced high grade ovarian carcinoma (aHGOC) receiving PARP inhibitors
Gervaso, L., Valenza, C., Mongillo, M., Boldrini, L., Bielo, L. Boscolo, Castellano, G., Guidi, L., Katrini, J., Nicolo, E., Pellizzari, G., Trapani, D., Cella, C.A., Lorenzetti, I.T., Derio, S., La Presa, M.T., Parma, G., Fazio, N., Curigliano, G., Khorana, A.A., Colombo, N.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article